454 related articles for article (PubMed ID: 22710668)
1. Wnt/β-catenin signalling in prostate cancer.
Kypta RM; Waxman J
Nat Rev Urol; 2012 Aug; 9(8):418-28. PubMed ID: 22710668
[TBL] [Abstract][Full Text] [Related]
2. Secreted Frizzled-related protein-1 is a negative regulator of androgen receptor activity in prostate cancer.
Kawano Y; Diez S; Uysal-Onganer P; Darrington RS; Waxman J; Kypta RM
Br J Cancer; 2009 Apr; 100(7):1165-74. PubMed ID: 19277043
[TBL] [Abstract][Full Text] [Related]
3. Multifaceted interaction between the androgen and Wnt signaling pathways and the implication for prostate cancer.
Terry S; Yang X; Chen MW; Vacherot F; Buttyan R
J Cell Biochem; 2006 Oct; 99(2):402-10. PubMed ID: 16741972
[TBL] [Abstract][Full Text] [Related]
4. Interplay between microRNAs and WNT/β-catenin signalling pathway regulates epithelial-mesenchymal transition in cancer.
Ghahhari NM; Babashah S
Eur J Cancer; 2015 Aug; 51(12):1638-49. PubMed ID: 26025765
[TBL] [Abstract][Full Text] [Related]
5. Intrinsic properties of Tcf1 and Tcf4 splice variants determine cell-type-specific Wnt/β-catenin target gene expression.
Wallmen B; Schrempp M; Hecht A
Nucleic Acids Res; 2012 Oct; 40(19):9455-69. PubMed ID: 22859735
[TBL] [Abstract][Full Text] [Related]
6. Wnt/β-catenin activation promotes prostate tumor progression in a mouse model.
Yu X; Wang Y; DeGraff DJ; Wills ML; Matusik RJ
Oncogene; 2011 Apr; 30(16):1868-79. PubMed ID: 21151173
[TBL] [Abstract][Full Text] [Related]
7. The androgen receptor can signal through Wnt/beta-Catenin in prostate cancer cells as an adaptation mechanism to castration levels of androgens.
Schweizer L; Rizzo CA; Spires TE; Platero JS; Wu Q; Lin TA; Gottardis MM; Attar RM
BMC Cell Biol; 2008 Jan; 9():4. PubMed ID: 18218096
[TBL] [Abstract][Full Text] [Related]
8. Effects of WNT/beta-catenin pathway activation on signaling through T-cell factor and androgen receptor in prostate cancer cell lines.
Cronauer MV; Schulz WA; Ackermann R; Burchardt M
Int J Oncol; 2005 Apr; 26(4):1033-40. PubMed ID: 15753999
[TBL] [Abstract][Full Text] [Related]
9. SNAIL1 employs β-Catenin-LEF1 complexes to control colorectal cancer cell invasion and proliferation.
Freihen V; Rönsch K; Mastroianni J; Frey P; Rose K; Boerries M; Zeiser R; Busch H; Hecht A
Int J Cancer; 2020 Apr; 146(8):2229-2242. PubMed ID: 31463973
[TBL] [Abstract][Full Text] [Related]
10. The transcription factor LEF-1 induces an epithelial-mesenchymal transition in MDCK cells independent of β-catenin.
Kobayashi W; Ozawa M
Biochem Biophys Res Commun; 2013 Dec; 442(1-2):133-8. PubMed ID: 24269234
[TBL] [Abstract][Full Text] [Related]
11. The metastasis suppressor CD82/KAI1 represses the TGF-β
Lee MS; Lee J; Kim YM; Lee H
Prostate; 2019 Sep; 79(12):1400-1411. PubMed ID: 31212375
[TBL] [Abstract][Full Text] [Related]
12. Differentiation-inducing factor-1 alters canonical Wnt signaling and suppresses alkaline phosphatase expression in osteoblast-like cell lines.
Matsuzaki E; Takahashi-Yanaga F; Miwa Y; Hirata M; Watanabe Y; Sato N; Morimoto S; Hirofuji T; Maeda K; Sasaguri T
J Bone Miner Res; 2006 Aug; 21(8):1307-16. PubMed ID: 16869729
[TBL] [Abstract][Full Text] [Related]
13. VBP1 modulates Wnt/β-catenin signaling by mediating the stability of the transcription factors TCF/LEFs.
Zhang H; Rong X; Wang C; Liu Y; Lu L; Li Y; Zhao C; Zhou J
J Biol Chem; 2020 Dec; 295(49):16826-16839. PubMed ID: 32989053
[TBL] [Abstract][Full Text] [Related]
14. Wnt/β-catenin pathway regulates bone morphogenetic protein (BMP2)-mediated differentiation of dental follicle cells.
Silvério KG; Davidson KC; James RG; Adams AM; Foster BL; Nociti FH; Somerman MJ; Moon RT
J Periodontal Res; 2012 Jun; 47(3):309-19. PubMed ID: 22150562
[TBL] [Abstract][Full Text] [Related]
15. Distinct roles for Xenopus Tcf/Lef genes in mediating specific responses to Wnt/beta-catenin signalling in mesoderm development.
Liu F; van den Broek O; Destrée O; Hoppler S
Development; 2005 Dec; 132(24):5375-85. PubMed ID: 16291789
[TBL] [Abstract][Full Text] [Related]
16. O2 regulates stem cells through Wnt/β-catenin signalling.
Mazumdar J; O'Brien WT; Johnson RS; LaManna JC; Chavez JC; Klein PS; Simon MC
Nat Cell Biol; 2010 Oct; 12(10):1007-13. PubMed ID: 20852629
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of nuclear Wnt signalling: challenges of an elusive target for cancer therapy.
Lyou Y; Habowski AN; Chen GT; Waterman ML
Br J Pharmacol; 2017 Dec; 174(24):4589-4599. PubMed ID: 28752891
[TBL] [Abstract][Full Text] [Related]
18. Revisiting the role of Wnt/β-catenin signaling in prostate cancer.
Schneider JA; Logan SK
Mol Cell Endocrinol; 2018 Feb; 462(Pt A):3-8. PubMed ID: 28189566
[TBL] [Abstract][Full Text] [Related]
19. Wnt activation promotes neuronal differentiation of glioblastoma.
Rampazzo E; Persano L; Pistollato F; Moro E; Frasson C; Porazzi P; Della Puppa A; Bresolin S; Battilana G; Indraccolo S; Te Kronnie G; Argenton F; Tiso N; Basso G
Cell Death Dis; 2013 Feb; 4(2):e500. PubMed ID: 23429286
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of Sox7 is associated with aberrant activation of Wnt/b-catenin signaling in endometrial cancer.
Chan DW; Mak CS; Leung TH; Chan KK; Ngan HY
Oncotarget; 2012 Dec; 3(12):1546-56. PubMed ID: 23295859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
